Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
HSS Journal ®
Published in: HSS Journal ® 2/2020

01-12-2020 | Tranexamic Acid | Original Article

Use of Topical Tranexamic Acid Reduces Direct and Indirect Blood Loss and Transfusion Rates in Revision Total Hip Arthroplasty

Authors: Elina Huerfano, MD, Manuel Huerfano, MD, MSc, Kate Shanaghan, BA, Maureen Barlow, PA-C, Stavros Memtsoudis, MD, PhD, Alejandro Gonzalez Della Valle, MD

Published in: HSS Journal ® | Special Issue 2/2020

Login to get access

Abstract

Background

In primary total hip arthroplasty (THA), evidence supports the use of tranexamic acid (TXA) as an effective strategy for reducing blood loss, but scant evidence supports its use in revision THA.

Questions/Purposes

We aimed to evaluate whether the use of topical TXA in revision THA is associated with less blood loss and lower transfusion rates and to assess its safety, specifically as it relates to thromboembolic complications.

Methods

In this retrospective comparative study, two groups who underwent revision THA between 2005 and 2017 were defined: 98 patients who received 3 g of topical TXA (study group) and 475 patients who did not receive TXA (control group). Subjects were divided into subgroups according to the type of revision. Hemoglobin and hematocrit levels, blood loss, and transfusions were recorded. The follow-up period was 6 weeks.

Results

Median estimated blood loss, hidden blood loss, hemoglobin drop, and transfusion rates were significantly lower in the study group. The rates of post-operative thromboembolism were similar in the two groups. According to subgroup analysis, patients with revision of the femoral component, both components, and staged exchange revisions showed significantly lower rates of transfusion.

Conclusion

Topical TXA administration during revision THA effectively reduced direct and indirect blood loss, including hidden losses, without increasing the rates of thromboembolic events. This effect appeared to be enhanced when the femoral component was revised.
Appendix
Available only for authorised users
Literature
1.
Alshryda S, Sukeik M, Sarda P, Blenkinsopp J, Haddad FS, Mason JM. A systematic review and meta-analysis of the topical administration of tranexamic acid in total hip and knee replacement. Bone Joint J. 2014;96-B(8):1005–1015.CrossRef
2.
Bedard NA, Pugely AJ, Lux NR, Liu SS, Gao Y, Callaghan JJ. Recent trends in blood utilization after primary hip and knee arthroplasty. J Arthroplasty. 2017;32(3):724–727.CrossRef
3.
Bozic KJ, Kamath AF, Ong K, et al. Comparative epidemiology of revision arthroplasty: failed THA poses greater clinical and economic burdens than failed TKA. Clin Orthop Relat Res. 2015;473(6):2131–2138.CrossRef
4.
Burnett RA, Bedard NA, DeMik DE, Gao Y, Liu SS, Callaghan JJ. Recent trends in blood utilization after revision hip and knee arthroplasty. J Arthroplasty. 2017;32(12):3693–3697.CrossRef
5.
Chen ZY, Gao Y, Chen W, Li X, Zhang YZ. Is wound drainage necessary in hip arthroplasty? A meta-analysis of randomized controlled trials. Eur J Orthop Surg Traumatol. 2014;24(6):939–946.CrossRef
6.
Gibon E, Courpied JP, Hamadouche M. Total joint replacement and blood loss: What is the best equation? Int Orthop. 2013;37(4):735–739.CrossRef
7.
Gonzalez Della Valle A, Slullitel G, Vestri R, Comba F, Buttaro M, Piccaluga F. No need for routine closed suction drainage in elective arthroplasty of the hip: prospective randomized trial in 104 operations. Acta Orthop Scand. 2004;75:30–33.CrossRef
8.
Gonzalez Della Valle A, Serota A, Go G, et al. Venous thromboembolism is rare with a multimodal prophylaxis protocol after total hip arthroplasty. Clin Orthop Relat Res. 2006;444:146–153.CrossRef
9.
Good L, Peterson E, Lisander B. Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement. Br J Anaesth. 2003;90(5):596–599.CrossRef
10.
Gross JB. Estimating allowable blood loss: corrected for dilution. Anesthesiology. 1983;58:277–280.CrossRef
11.
Huerfano E, Huerfano M, Shanaghan KA, Gonzalez Della Valle A. Topical tranexamic acid in revision total knee arthroplasty reduces transfusion rates and may be associated with earlier recovery. J Arthroplasty. 2019;34(7S):S249–S255.CrossRef
12.
Kazi HA, Fountain JR, Thomas TG, Carroll FA. The effect of bolus administration of tranexamic acid in revision hip arthroplasty. Hip Int. 2012;22(6):615–620.CrossRef
13.
Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007;89(4):780–785.CrossRef
14.
Lei Y, Huang Q, Huang Z, Xie J, Chen G, Pei F. Multiple-dose intravenous tranexamic acid further reduces hidden blood loss after total hip arthroplasty: a randomized controlled trial. J Arthroplasty. 2018;33(9):2940–2945.CrossRef
15.
Mariani P, Buttaro MA, Slullitel PA, et al. Transfusion rate using intravenous tranexamic acid in hip revision surgery. Hip Int. 2018; 28(2):194–199.CrossRef
16.
Nadler SB, Hidalgo JH, Bloch T. Prediction of blood volume in normal human adults. Surgery. 1962;51(2):224–232.PubMed
17.
Noordin S, Waters TS, Garbuz DS, Duncan CP, Masri BA. Tranexamic acid reduces allogenic transfusion in revision hip arthroplasty. Clin Orthop Relat Res. 2011;469(2):541–546.CrossRef
18.
Pagnano M, Cushner FD, Hansen A, Scuderi GR, Scott WN. Blood management in two-stage revision knee arthroplasty for deep prosthetic infection. Clin Orthop Relat Res. 1999;367:238–242.
19.
Park KJ, Couch CG, Edwards PK, Siegel ER, Mears SC, Barnes CL. Tranexamic acid reduces blood transfusions in revision total hip arthroplasty. J Arthroplasty. 2016;31(12):2850–2855.e1.CrossRef
20.
Parker MJ, Roberts CP, Hay D. Closed suction drainage for hip and knee arthroplasty: a meta-analysis. J Bone Joint Surg Am. 2004;86(6):1146–1152.CrossRef
21.
Peck J, Kepecs DM, Mei B, et al. The effect of preoperative administration of intravenous tranexamic acid during revision hip arthroplasty: a retrospective study. J Bone Joint Surg Am. 2018;100(17):1509–1516.CrossRef
22.
Phillips SJ. Does salvage and tranexamic acid reduce the need for blood transfusion in revision hip surgery? J Bone Joint Surg Br. 2006;88(9):1141–1142.CrossRef
23.
Sehat KR, Evans RL, Newman JH. Hidden blood loss following hip and knee arthroplasty. Correct management of blood loss should take hidden loss into account. J Bone Joint Surg Br. 2004;86(4):561–565.CrossRef
24.
Serrano Mateo L, Goudarz Mehdikhani K, Cáceres L, Lee Y, Gonzalez Della Valle A. Topical tranexamic acid may improve early functional outcomes of primary total knee arthroplasty. J Arthroplasty. 2016;31(7):1449–1452.CrossRef
25.
Sukeik M, Alshryda S, Haddad FS, Mason JM. Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement. J Bone Joint Surg Br. 2011;93(1):39–46.CrossRef
26.
Wang J, Wang Q, Zhang X, Wang Q. Intra-articular application is more effective than intravenous application of tranexamic acid in total knee arthroplasty: a prospective randomized controlled trial. J Arthroplasty. 2017;32(11):3385–3389.CrossRef
27.
Wu Y, Zeng Y, Yang T, Si H, Cao F, Shen B. The efficacy and safety of combination of intravenous and topical tranexamic acid in revision hip arthroplasty: a randomized, controlled trial. J Arthroplasty. 2016;31(11):2548–2553.CrossRef
28.
Xie J, Hu Q, Ma J, Huang Q, Pei F. Multiple boluses of intravenous tranexamic acid to reduce hidden blood loss and the inflammatory response following enhanced recovery primary total hip arthroplasty: a randomised clinical trial. Bone Joint J. 2017;99-B(11):1442–1449.CrossRef
29.
Zhou XD, Li J, Xiong Y, Jiang LF, Li WJ, Wu LD. Do we really need closed-suction drainage in total hip arthroplasty? A meta-analysis. Int Orthop. 2013;37(11):2109–2118.CrossRef
Metadata
Title
Use of Topical Tranexamic Acid Reduces Direct and Indirect Blood Loss and Transfusion Rates in Revision Total Hip Arthroplasty
Authors
Elina Huerfano, MD
Manuel Huerfano, MD, MSc
Kate Shanaghan, BA
Maureen Barlow, PA-C
Stavros Memtsoudis, MD, PhD
Alejandro Gonzalez Della Valle, MD
Publication date
01-12-2020
Publisher
Springer US
Published in
HSS Journal ® / Issue Special Issue 2/2020
Print ISSN: 1556-3316
Electronic ISSN: 1556-3324
DOI
https://doi.org/10.1007/s11420-019-09718-7

Other articles of this Special Issue 2/2020

HSS Journal ® 2/2020 Go to the issue

Original Article

ACL Reconstruction Graft Angle and Outcomes: Transtibial vs Anteromedial Reconstruction

Original Article

Correlation Between the PROMIS Pediatric Mobility Instrument and the Hospital for Special Surgery Pediatric Functional Activity Brief Scale (HSS Pedi-FABS)

Original Article

Survivorship of a Medialized Glenoid and Lateralized Onlay Humerus Reverse Shoulder Arthroplasty Is High at Midterm Follow-up

Original Article

Sagittal Tibiotalar Alignment May Not Affect Functional Outcomes in Fixed-Bearing Total Ankle Replacement: A Retrospective Cohort Study

Radiology & Imaging Corner

Using Magnetic Resonance Imaging to Identify Complications Associated with Bioabsorbable Implant Fixation of Osteochondral Lesions: A Practical Guide

Original Article

The Clavicle Continues to Grow During Adolescence and Early Adulthood